These findings suggest that FOSL1 promotes TMZ chemoresistance by regulating IL‐6‐pSTAT3Tyr705‐mediated stemness in GBM cells, making it a promising therapeutic target to overcome chemoresistance in GBM. The gene discussed is FOSL1; the disease is glioblastoma.